l 636499 has been researched along with sq 29548 in 1 studies
Studies (l 636499) | Trials (l 636499) | Recent Studies (post-2010) (l 636499) | Studies (sq 29548) | Trials (sq 29548) | Recent Studies (post-2010) (sq 29548) |
---|---|---|---|---|---|
9 | 0 | 0 | 515 | 0 | 41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doran, J; Fitzgerald, DJ; FitzGerald, GA; Jackson, E | 1 |
1 other study(ies) available for l 636499 and sq 29548
Article | Year |
---|---|
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Bridged Bicyclo Compounds, Heterocyclic; Coronary Vessels; Dibenzothiepins; Dogs; Fatty Acids, Unsaturated; Hydrazines; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides; Prostanoic Acids; Rats; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2 | 1986 |